Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 7
2005 1
2007 1
2010 2
2011 1
2012 4
2013 4
2015 5
2016 2
2017 3
2019 2
2020 9
2021 7
2022 1
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Marinomonas mediterranea synthesizes an R-type bacteriocin.
Lucas-Elío P, ElAlami T, Martínez A, Sanchez-Amat A. Lucas-Elío P, et al. Among authors: martinez a. Appl Environ Microbiol. 2024 Jan 24;90(1):e0127323. doi: 10.1128/aem.01273-23. Epub 2024 Jan 3. Appl Environ Microbiol. 2024. PMID: 38169292 Free PMC article.
Surgical treatment trends and outcomes for anal fistula: fistulotomy is still accurate and safe. Results from a nationwide observational study.
Cano-Valderrama Ó, Miguel TF, Bonito AC, Muriel JS, Fernández FJM, Ros EP, Cabrera AMG, Cerdán-Santacruz C; Grupo Joven de la Asociación Española de Coloproctología (GJ-AECP): Grupo de trabajo sobre fístula anal (Collaborative Group). Cano-Valderrama Ó, et al. Tech Coloproctol. 2023 Oct;27(10):909-919. doi: 10.1007/s10151-023-02842-x. Epub 2023 Jul 17. Tech Coloproctol. 2023. PMID: 37460829
Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study.
Moyá-Amengual A, Ruiz-García A, Pallarés-Carratalá V, Serrano-Cumplido A, Prieto-Díaz MÁ, Segura-Fragoso A, Cinza-Sanjurjo S; researchers of the IBERICAN study. Moyá-Amengual A, et al. Front Cardiovasc Med. 2023 May 9;10:1090458. doi: 10.3389/fcvm.2023.1090458. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37229234 Free PMC article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii.
Batista-Duharte A, Sendra L, Herrero MJ, Portuondo DL, Téllez-Martínez D, Olivera G, Fernández-Delgado M, Javega B, Herrera G, Martínez A, Costa PI, Zeppone Carlos I, Aliño SF. Batista-Duharte A, et al. Among authors: martinez a. Int J Mol Sci. 2021 Mar 27;22(7):3470. doi: 10.3390/ijms22073470. Int J Mol Sci. 2021. PMID: 33801683 Free PMC article.
55 results